Discovery of novel non-peptidic ketopiperazine-based renin inhibitors.
2005
Ketopiperazine 2 was designed from a previously published analog. Compound 2 was shown to be a novel, potent inhibitor of renin that, when administered orally, lowered blood pressure in a hypertensive double transgenic (human renin and angiotensinogen) mouse model. Compound 2 was further optimized to sub-nanomolar potency by designing an analog that addressed the S3 sub-pocket of the renin enzyme (16).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
18
References
25
Citations
NaN
KQI